COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,140 Articles (22,693 medRxiv, 8,447 bioRxiv)

Most recent first Previous |  Page 2837: Articles 28361-28370  | Next

Agent-Level Pandemic Simulation (ALPS) for Analyzing Effects of Lockdown Measures
Srivastava, A.
10.1101/2020.04.29.20084699 — Posted: 2020-05-05
Vitamin D status, body mass index, ethnicity and COVID-19: Initial analysis of the first-reported UK Biobank COVID-19 positive cases (n 580) compared with negative controls (n 723)
Darling, A. L., Ahmadi, K. R., Ward, K. A., Harvey, N. C., Couto Alves, A., Dunn-Waters, D. K., Lanham-New, S. A., Cooper, C., Blackbourn, D. J.
10.1101/2020.04.29.20084277 — Posted: 2020-05-05 Discussion: Onsite
COVID-19 length of hospital stay: a systematic review and data synthesis
Rees, E. M., Nightingale, E. S., Jafari, Y., Waterlow, N., Clifford, S., CMMID Working Group, , Jombert, T., Procter, S. R., Knight, G. M.
10.1101/2020.04.30.20084780 — Posted: 2020-05-05
Pre-Existing Characteristics Associated with Covid-19 Illness Severity
Ebinger, J. E., Achamallah, N., Ji, H., Claggett, B. L., Sun, N., Botting, P., Nguyen, T.-T., Luong, E., Kim, E. H., Park, E., Liu, Y., Rosenberry, R., Matusov, Y., Zhao, S., Pedraza, I., Zaman, T., Thompson, M., Raedschelders, K., Berg, A. H., Grein, J. D., Noble, P. W., Chugh, S. S., Bairey Merz, C. N., Marban, E., Van Eyk, J. E., Solomon, S. D., Albert, C. M., Chen, P., Cheng, S.
10.1101/2020.04.29.20084533 — Posted: 2020-05-05 Discussion: Onsite
Disruption of the CCL5/RANTES-CCR5 Pathway Restores Immune Homeostasis and Reduces Plasma Viral Load in Critical COVID-19
Patterson, B. K., Seethamraju, H., Dhody, K., Corley, M. J., Kazempour, K., Lalezari, J. P., Pang, A. P., Sugai, C., Francisco, E. B., Pise, A., Rodrigues, H., Ryou, M., Wu, H. L., Webb, G. M., Park, B. S., Kelly, S., Pourhassan, N., Lelic, A., Kdouh, L., Herrera, M., Hall, E., Aklin, E., Ndhlovu, L., Sacha, J. B.
10.1101/2020.05.02.20084673 — Posted: 2020-05-05 Discussion: Offsite
Forecasting Novel Corona Positive Cases in Indiausing Truncated Information: A Mathematical Approach
Singh, B. P.
10.1101/2020.04.29.20085175 — Posted: 2020-05-05
Patient-Led COVID-19 Triage Systems and Case Fatality Rates: A Comparative Study Between Singapore, Japan, Norway, the USA and the UK.
Mansab, F., Bhatti, S., Goyal, D.
10.1101/2020.04.28.20084079 — Posted: 2020-05-05
Battling the COVID-19 Pandemic: Is Bangladesh Prepared?
Rahaman Khan, H., Howlader, T., Islam, M. M.
10.1101/2020.04.29.20084236 — Posted: 2020-05-05
A model to estimate demand for personal protective equipment for Ontario acute care hospitals during the COVID-19 pandemic
Barrett, K. A., Nakamachi, Y., Ierasts, T., Khan, Y., Mac, S., Naimark, D., Stall, N., Ximenes, R., Morris, A., Sander, B.
10.1101/2020.04.29.20085142 — Posted: 2020-05-05
News from the front: Excess mortality and life expectancy in two major epicentres of the COVID-19 pandemic in Italy
Ghislandi, S., Muttarak, R., Sauerberg, M., Scotti, B.
10.1101/2020.04.29.20084335 — Posted: 2020-05-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).